{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Functional Approach"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "c:\\Users\\User\\anaconda3\\envs\\NER\\Lib\\site-packages\\tqdm\\auto.py:21: TqdmWarning: IProgress not found. Please update jupyter and ipywidgets. See https://ipywidgets.readthedocs.io/en/stable/user_install.html\n",
      "  from .autonotebook import tqdm as notebook_tqdm\n",
      "Asking to truncate to max_length but no maximum length is provided and the model has no predefined maximum length. Default to no truncation.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Raw OpenAI Response: ```json\n",
      "[\n",
      "    {\n",
      "        \"source\": \"Tirzepatide\",\n",
      "        \"source_type\": \"DETAILED_DESCRIPTION\",\n",
      "        \"target\": \"Type 2 Diabetes\",\n",
      "        \"target_type\": \"DETAILED_DESCRIPTION\",\n",
      "        \"relationship\": \"TREATS\",\n",
      "        \"evidence\": \"Tirzepatide was statistically superior to insulin lispro in reducing HbA1c levels in patients with Type 2 Diabetes.\"\n",
      "    },\n",
      "    {\n",
      "        \"source\": \"Tirzepatide\",\n",
      "        \"source_type\": \"DETAILED_DESCRIPTION\",\n",
      "        \"target\": \"Insulin Lispro\",\n",
      "        \"target_type\": \"DETAILED_DESCRIPTION\",\n",
      "        \"relationship\": \"TREATS\",\n",
      "        \"evidence\": \"Tirzepatide was statistically superior to insulin lispro for all doses in reducing HbA1c levels.\"\n",
      "    },\n",
      "    {\n",
      "        \"source\": \"Tirzepatide\",\n",
      "        \"source_type\": \"DETAILED_DESCRIPTION\",\n",
      "        \"target\": \"Insulin Lispro\",\n",
      "        \"target_type\": \"DETAILED_DESCRIPTION\",\n",
      "        \"relationship\": \"TREATS\",\n",
      "        \"evidence\": \"All tirzepatide doses were superior to insulin lispro in reducing body weight.\"\n",
      "    },\n",
      "    {\n",
      "        \"source\": \"Tirzepatide\",\n",
      "        \"source_type\": \"DETAILED_DESCRIPTION\",\n",
      "        \"target\": \"Insulin Lispro\",\n",
      "        \"target_type\": \"DETAILED_DESCRIPTION\",\n",
      "        \"relationship\": \"ASSOCIATED_WITH\",\n",
      "        \"evidence\": \"Greater reductions in fasting serum glucose were observed with all tirzepatide doses compared to insulin lispro.\"\n",
      "    },\n",
      "    {\n",
      "        \"source\": \"Tirzepatide\",\n",
      "        \"source_type\": \"DETAILED_DESCRIPTION\",\n",
      "        \"target\": \"Insulin Lispro\",\n",
      "        \"target_type\": \"DETAILED_DESCRIPTION\",\n",
      "        \"relationship\": \"ASSOCIATED_WITH\",\n",
      "        \"evidence\": \"Reductions in mean daily 2-hour postprandial glucose were greater with tirzepatide compared to insulin lispro.\"\n",
      "    }\n",
      "]\n",
      "```\n",
      "Error in relation extraction: Expecting value: line 1 column 1 (char 0)\n",
      "entities:  [('33', 'DETAILED_DESCRIPTION'), ('Medical', 'DETAILED_DESCRIPTION'), ('network', 'DETAILED_DESCRIPTION'), ('/02/2024', 'DETAILED_DESCRIPTION'), ('19', 'DETAILED_DESCRIPTION'), ('2020', 'DETAILED_DESCRIPTION'), ('1', 'DETAILED_DESCRIPTION'), ('267 participants', 'DETAILED_DESCRIPTION'), ('28 participants', 'DETAILED_DESCRIPTION'), ('25', 'DETAILED_DESCRIPTION'), ('least one dose', 'DETAILED_DESCRIPTION'), ('treatment', 'DETAILED_DESCRIPTION'), ('59 years', 'DETAILED_DESCRIPTION'), ('24 participants', 'DETAILED_DESCRIPTION'), ('years', 'DETAILED_DESCRIPTION'), ('1c', 'DETAILED_DESCRIPTION'), ('.8%', 'DETAILED_DESCRIPTION'), ('weight', 'DETAILED_DESCRIPTION'), ('.5 kg', 'DETAILED_DESCRIPTION'), ('serum glucose', 'DETAILED_DESCRIPTION'), ('157 mg/dL', 'LAB_VALUE'), ('insulin glargine', 'DETAILED_DESCRIPTION'), ('46', 'DETAILED_DESCRIPTION'), ('IU', 'LAB_VALUE'), ('/day', 'DETAILED_DESCRIPTION'), ('.53 IU/kg/day', 'DETAILED_DESCRIPTION'), ('ethnic representation', 'DETAILED_DESCRIPTION'), ('13% Black', 'DETAILED_DESCRIPTION'), ('53% Hispanic participants', 'DETAILED_DESCRIPTION'), ('%', 'DETAILED_DESCRIPTION'), ('participants', 'DETAILED_DESCRIPTION'), ('trial treatment', 'DETAILED_DESCRIPTION'), ('92%', 'DETAILED_DESCRIPTION'), ('zepatide groups', 'DETAILED_DESCRIPTION'), ('lispro', 'DETAILED_DESCRIPTION'), ('treatment discontinuation', 'DETAILED_DESCRIPTION'), ('zepatide', 'DETAILED_DESCRIPTION'), ('events', 'DETAILED_DESCRIPTION'), ('gastrointestinal issues', 'DETAILED_DESCRIPTION'), ('8.8%', 'LAB_VALUE'), ('mmol/mol', 'LAB_VALUE'), ('1c reduction', 'LAB_VALUE'), ('−2.1%', 'LAB_VALUE'), ('−1.1%', 'LAB_VALUE'), ('pro', 'DETAILED_DESCRIPTION'), ('52', 'DATE'), ('6.7%', 'LAB_VALUE'), ('zepatide group', 'DETAILED_DESCRIPTION'), ('.7%', 'DETAILED_DESCRIPTION'), ('superior', 'LAB_VALUE'), ('−0.98%', 'LAB_VALUE'), ('c', 'DIAGNOSTIC_PROCEDURE'), ('−1.9%', 'LAB_VALUE'), ('5 mg tirzepatide', 'DETAILED_DESCRIPTION'), ('−2.2%', 'LAB_VALUE'), ('10 mg tirzepatide', 'DETAILED_DESCRIPTION'), ('−2.3%', 'LAB_VALUE'), ('15 mg tirzepatide Tirzepatide was statistically superior to insulin lispro for all doses', 'DETAILED_DESCRIPTION'), ('5 mg', 'LAB_VALUE'), ('−0.79%', 'LAB_VALUE'), ('mg', 'LAB_VALUE'), ('−1.01%', 'LAB_VALUE'), ('−1.13%', 'LAB_VALUE'), ('HbA1c', 'DIAGNOSTIC_PROCEDURE'), ('individual', 'DETAILED_DESCRIPTION'), ('tirzepatide doses', 'DETAILED_DESCRIPTION'), ('less than 7.0%', 'LAB_VALUE'), ('68', 'LAB_VALUE'), ('tirzepatide-treated', 'DETAILED_DESCRIPTION'), ('36', 'LAB_VALUE'), ('insulin lispro-treated', 'DETAILED_DESCRIPTION'), ('Body Weight Changes', 'DIAGNOSTIC_PROCEDURE'), ('90 kg', 'LAB_VALUE'), ('body weight', 'DIAGNOSTIC_PROCEDURE'), ('−9.0 kg', 'LAB_VALUE'), ('tirzepatide', 'DETAILED_DESCRIPTION'), ('−3.2 kg', 'LAB_VALUE'), ('with insulin lispro', 'DETAILED_DESCRIPTION'), ('week 52', 'DATE'), ('−6.7 kg', 'LAB_VALUE'), ('with 5 mg tirzepatide', 'DETAILED_DESCRIPTION'), ('−9.2 kg', 'LAB_VALUE'), ('−11.0 kg', 'LAB_VALUE'), ('15 mg tirzepatide', 'DETAILED_DESCRIPTION'), ('All tirzepatide doses were superior to insulin lispro', 'DETAILED_DESCRIPTION'), ('reductions', 'LAB_VALUE'), ('fasting serum glucose', 'DIAGNOSTIC_PROCEDURE'), ('all', 'DETAILED_DESCRIPTION'), ('insulin lispro', 'DETAILED_DESCRIPTION'), ('mean daily', 'DETAILED_DESCRIPTION'), ('2-hour postprandial', 'DETAILED_DESCRIPTION'), ('glucose', 'DIAGNOSTIC_PROCEDURE'), ('7-point self-monitored blood glucose profile', 'DETAILED_DESCRIPTION'), ('65 to 78 mg/dL', 'LAB_VALUE'), ('65 mg/dL', 'LAB_VALUE'), ('≤6.5%', 'LAB_VALUE'), ('zepatide-treated', 'DETAILED_DESCRIPTION'), ('<5.7%', 'LAB_VALUE'), ('<7.', 'LAB_VALUE'), ('Basal Insulin', 'PERSON'), ('2', 'CARDINAL'), ('November 7, 2023', 'DATE'), ('330', 'CARDINAL'), ('Number 17', 'DATE'), ('1633', 'DATE'), ('2023', 'DATE'), ('American Medical Association', 'ORG'), ('F. Hoffmann - La Roche LTD', 'PERSON'), ('10/02/2024', 'DATE'), ('between October 19, 2020', 'DATE'), ('November 1, 2022', 'DATE'), ('2267', 'CARDINAL'), ('1428', 'DATE'), ('1425', 'DATE'), ('at least one', 'CARDINAL'), ('824', 'CARDINAL'), ('58%', 'PERCENT'), ('14 years', 'DATE'), ('90.5 kg', 'QUANTITY'), ('157', 'CARDINAL'), ('46 IU/day', 'DATE'), ('0.53 IU/kg/day', 'MONEY'), ('US', 'GPE'), ('13%', 'PERCENT'), ('53%', 'PERCENT'), ('Hispanic', 'NORP'), ('89%', 'PERCENT'), ('87%–92%', 'PERCENT'), ('87%', 'PERCENT'), ('6', 'CARDINAL'), ('73', 'CARDINAL'), ('7.7%', 'PERCENT'), ('2A', 'CARDINAL'), ('95%', 'PERCENT'), ('5', 'CARDINAL'), ('10', 'CARDINAL'), ('15', 'CARDINAL'), ('eFigure 4A', 'ORG'), ('68%', 'PERCENT'), ('483', 'CARDINAL'), ('716', 'CARDINAL'), ('36%', 'PERCENT'), ('256', 'CARDINAL'), ('kg', 'PERSON'), ('2B', 'CARDINAL'), ('Exploratory Endpoints\\nGreater', 'PERSON'), ('daily', 'DATE'), ('2-hour', 'TIME'), ('7', 'CARDINAL'), ('22%', 'PERCENT'), ('5.7%', 'PERCENT'), ('18%', 'PERCENT'), ('3%', 'PERCENT')]\n",
      "relations:  [{'source': '33', 'source_type': 'DETAILED_DESCRIPTION', 'target': 'Medical', 'target_type': 'DETAILED_DESCRIPTION', 'relationship': 'ASSOCIATED_WITH', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': 'Medical', 'source_type': 'DETAILED_DESCRIPTION', 'target': 'network', 'target_type': 'DETAILED_DESCRIPTION', 'relationship': 'USED_FOR', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': 'network', 'source_type': 'DETAILED_DESCRIPTION', 'target': '/02/2024', 'target_type': 'DETAILED_DESCRIPTION', 'relationship': 'TREATS', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '/02/2024', 'source_type': 'DETAILED_DESCRIPTION', 'target': '19', 'target_type': 'DETAILED_DESCRIPTION', 'relationship': 'CAUSES', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '19', 'source_type': 'DETAILED_DESCRIPTION', 'target': '2020', 'target_type': 'DETAILED_DESCRIPTION', 'relationship': 'INFLUENCES', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '2020', 'source_type': 'DETAILED_DESCRIPTION', 'target': '1', 'target_type': 'DETAILED_DESCRIPTION', 'relationship': 'MEASURED_BY', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '1', 'source_type': 'DETAILED_DESCRIPTION', 'target': '267 participants', 'target_type': 'DETAILED_DESCRIPTION', 'relationship': 'LOCATED_IN', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '267 participants', 'source_type': 'DETAILED_DESCRIPTION', 'target': '28 participants', 'target_type': 'DETAILED_DESCRIPTION', 'relationship': 'FUNDED_BY', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '28 participants', 'source_type': 'DETAILED_DESCRIPTION', 'target': '25', 'target_type': 'DETAILED_DESCRIPTION', 'relationship': 'REGULATED_BY', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '25', 'source_type': 'DETAILED_DESCRIPTION', 'target': 'least one dose', 'target_type': 'DETAILED_DESCRIPTION', 'relationship': 'ASSOCIATED_WITH', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': 'least one dose', 'source_type': 'DETAILED_DESCRIPTION', 'target': 'treatment', 'target_type': 'DETAILED_DESCRIPTION', 'relationship': 'USED_FOR', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': 'treatment', 'source_type': 'DETAILED_DESCRIPTION', 'target': '59 years', 'target_type': 'DETAILED_DESCRIPTION', 'relationship': 'TREATS', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '59 years', 'source_type': 'DETAILED_DESCRIPTION', 'target': '24 participants', 'target_type': 'DETAILED_DESCRIPTION', 'relationship': 'CAUSES', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '24 participants', 'source_type': 'DETAILED_DESCRIPTION', 'target': 'years', 'target_type': 'DETAILED_DESCRIPTION', 'relationship': 'INFLUENCES', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': 'years', 'source_type': 'DETAILED_DESCRIPTION', 'target': '1c', 'target_type': 'DETAILED_DESCRIPTION', 'relationship': 'MEASURED_BY', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '1c', 'source_type': 'DETAILED_DESCRIPTION', 'target': '.8%', 'target_type': 'DETAILED_DESCRIPTION', 'relationship': 'LOCATED_IN', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '.8%', 'source_type': 'DETAILED_DESCRIPTION', 'target': 'weight', 'target_type': 'DETAILED_DESCRIPTION', 'relationship': 'FUNDED_BY', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': 'weight', 'source_type': 'DETAILED_DESCRIPTION', 'target': '.5 kg', 'target_type': 'DETAILED_DESCRIPTION', 'relationship': 'REGULATED_BY', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '.5 kg', 'source_type': 'DETAILED_DESCRIPTION', 'target': 'serum glucose', 'target_type': 'DETAILED_DESCRIPTION', 'relationship': 'ASSOCIATED_WITH', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': 'serum glucose', 'source_type': 'DETAILED_DESCRIPTION', 'target': '157 mg/dL', 'target_type': 'LAB_VALUE', 'relationship': 'USED_FOR', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '157 mg/dL', 'source_type': 'LAB_VALUE', 'target': 'insulin glargine', 'target_type': 'DETAILED_DESCRIPTION', 'relationship': 'TREATS', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': 'insulin glargine', 'source_type': 'DETAILED_DESCRIPTION', 'target': '46', 'target_type': 'DETAILED_DESCRIPTION', 'relationship': 'CAUSES', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '46', 'source_type': 'DETAILED_DESCRIPTION', 'target': 'IU', 'target_type': 'LAB_VALUE', 'relationship': 'INFLUENCES', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': 'IU', 'source_type': 'LAB_VALUE', 'target': '/day', 'target_type': 'DETAILED_DESCRIPTION', 'relationship': 'MEASURED_BY', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '/day', 'source_type': 'DETAILED_DESCRIPTION', 'target': '.53 IU/kg/day', 'target_type': 'DETAILED_DESCRIPTION', 'relationship': 'LOCATED_IN', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '.53 IU/kg/day', 'source_type': 'DETAILED_DESCRIPTION', 'target': 'ethnic representation', 'target_type': 'DETAILED_DESCRIPTION', 'relationship': 'FUNDED_BY', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': 'ethnic representation', 'source_type': 'DETAILED_DESCRIPTION', 'target': '13% Black', 'target_type': 'DETAILED_DESCRIPTION', 'relationship': 'REGULATED_BY', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '13% Black', 'source_type': 'DETAILED_DESCRIPTION', 'target': '53% Hispanic participants', 'target_type': 'DETAILED_DESCRIPTION', 'relationship': 'ASSOCIATED_WITH', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '53% Hispanic participants', 'source_type': 'DETAILED_DESCRIPTION', 'target': '%', 'target_type': 'DETAILED_DESCRIPTION', 'relationship': 'USED_FOR', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '%', 'source_type': 'DETAILED_DESCRIPTION', 'target': 'participants', 'target_type': 'DETAILED_DESCRIPTION', 'relationship': 'TREATS', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': 'participants', 'source_type': 'DETAILED_DESCRIPTION', 'target': 'trial treatment', 'target_type': 'DETAILED_DESCRIPTION', 'relationship': 'CAUSES', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': 'trial treatment', 'source_type': 'DETAILED_DESCRIPTION', 'target': '92%', 'target_type': 'DETAILED_DESCRIPTION', 'relationship': 'INFLUENCES', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '92%', 'source_type': 'DETAILED_DESCRIPTION', 'target': 'zepatide groups', 'target_type': 'DETAILED_DESCRIPTION', 'relationship': 'MEASURED_BY', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': 'zepatide groups', 'source_type': 'DETAILED_DESCRIPTION', 'target': 'lispro', 'target_type': 'DETAILED_DESCRIPTION', 'relationship': 'LOCATED_IN', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': 'lispro', 'source_type': 'DETAILED_DESCRIPTION', 'target': 'treatment discontinuation', 'target_type': 'DETAILED_DESCRIPTION', 'relationship': 'FUNDED_BY', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': 'treatment discontinuation', 'source_type': 'DETAILED_DESCRIPTION', 'target': 'zepatide', 'target_type': 'DETAILED_DESCRIPTION', 'relationship': 'REGULATED_BY', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': 'zepatide', 'source_type': 'DETAILED_DESCRIPTION', 'target': 'events', 'target_type': 'DETAILED_DESCRIPTION', 'relationship': 'ASSOCIATED_WITH', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': 'events', 'source_type': 'DETAILED_DESCRIPTION', 'target': 'gastrointestinal issues', 'target_type': 'DETAILED_DESCRIPTION', 'relationship': 'USED_FOR', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': 'gastrointestinal issues', 'source_type': 'DETAILED_DESCRIPTION', 'target': '8.8%', 'target_type': 'LAB_VALUE', 'relationship': 'TREATS', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '8.8%', 'source_type': 'LAB_VALUE', 'target': 'mmol/mol', 'target_type': 'LAB_VALUE', 'relationship': 'CAUSES', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': 'mmol/mol', 'source_type': 'LAB_VALUE', 'target': '1c reduction', 'target_type': 'LAB_VALUE', 'relationship': 'INFLUENCES', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '1c reduction', 'source_type': 'LAB_VALUE', 'target': '−2.1%', 'target_type': 'LAB_VALUE', 'relationship': 'MEASURED_BY', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '−2.1%', 'source_type': 'LAB_VALUE', 'target': '−1.1%', 'target_type': 'LAB_VALUE', 'relationship': 'LOCATED_IN', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '−1.1%', 'source_type': 'LAB_VALUE', 'target': 'pro', 'target_type': 'DETAILED_DESCRIPTION', 'relationship': 'FUNDED_BY', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': 'pro', 'source_type': 'DETAILED_DESCRIPTION', 'target': '52', 'target_type': 'DATE', 'relationship': 'REGULATED_BY', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '52', 'source_type': 'DATE', 'target': '6.7%', 'target_type': 'LAB_VALUE', 'relationship': 'ASSOCIATED_WITH', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '6.7%', 'source_type': 'LAB_VALUE', 'target': 'zepatide group', 'target_type': 'DETAILED_DESCRIPTION', 'relationship': 'USED_FOR', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': 'zepatide group', 'source_type': 'DETAILED_DESCRIPTION', 'target': '.7%', 'target_type': 'DETAILED_DESCRIPTION', 'relationship': 'TREATS', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '.7%', 'source_type': 'DETAILED_DESCRIPTION', 'target': 'superior', 'target_type': 'LAB_VALUE', 'relationship': 'CAUSES', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': 'superior', 'source_type': 'LAB_VALUE', 'target': '−0.98%', 'target_type': 'LAB_VALUE', 'relationship': 'INFLUENCES', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '−0.98%', 'source_type': 'LAB_VALUE', 'target': 'c', 'target_type': 'DIAGNOSTIC_PROCEDURE', 'relationship': 'MEASURED_BY', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': 'c', 'source_type': 'DIAGNOSTIC_PROCEDURE', 'target': '−1.9%', 'target_type': 'LAB_VALUE', 'relationship': 'LOCATED_IN', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '−1.9%', 'source_type': 'LAB_VALUE', 'target': '5 mg tirzepatide', 'target_type': 'DETAILED_DESCRIPTION', 'relationship': 'FUNDED_BY', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '5 mg tirzepatide', 'source_type': 'DETAILED_DESCRIPTION', 'target': '−2.2%', 'target_type': 'LAB_VALUE', 'relationship': 'REGULATED_BY', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '−2.2%', 'source_type': 'LAB_VALUE', 'target': '10 mg tirzepatide', 'target_type': 'DETAILED_DESCRIPTION', 'relationship': 'ASSOCIATED_WITH', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '10 mg tirzepatide', 'source_type': 'DETAILED_DESCRIPTION', 'target': '−2.3%', 'target_type': 'LAB_VALUE', 'relationship': 'USED_FOR', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '−2.3%', 'source_type': 'LAB_VALUE', 'target': '15 mg tirzepatide Tirzepatide was statistically superior to insulin lispro for all doses', 'target_type': 'DETAILED_DESCRIPTION', 'relationship': 'TREATS', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '15 mg tirzepatide Tirzepatide was statistically superior to insulin lispro for all doses', 'source_type': 'DETAILED_DESCRIPTION', 'target': '5 mg', 'target_type': 'LAB_VALUE', 'relationship': 'CAUSES', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '5 mg', 'source_type': 'LAB_VALUE', 'target': '−0.79%', 'target_type': 'LAB_VALUE', 'relationship': 'INFLUENCES', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '−0.79%', 'source_type': 'LAB_VALUE', 'target': 'mg', 'target_type': 'LAB_VALUE', 'relationship': 'MEASURED_BY', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': 'mg', 'source_type': 'LAB_VALUE', 'target': '−1.01%', 'target_type': 'LAB_VALUE', 'relationship': 'LOCATED_IN', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '−1.01%', 'source_type': 'LAB_VALUE', 'target': '−1.13%', 'target_type': 'LAB_VALUE', 'relationship': 'FUNDED_BY', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '−1.13%', 'source_type': 'LAB_VALUE', 'target': 'HbA1c', 'target_type': 'DIAGNOSTIC_PROCEDURE', 'relationship': 'REGULATED_BY', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': 'HbA1c', 'source_type': 'DIAGNOSTIC_PROCEDURE', 'target': 'individual', 'target_type': 'DETAILED_DESCRIPTION', 'relationship': 'ASSOCIATED_WITH', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': 'individual', 'source_type': 'DETAILED_DESCRIPTION', 'target': 'tirzepatide doses', 'target_type': 'DETAILED_DESCRIPTION', 'relationship': 'USED_FOR', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': 'tirzepatide doses', 'source_type': 'DETAILED_DESCRIPTION', 'target': 'less than 7.0%', 'target_type': 'LAB_VALUE', 'relationship': 'TREATS', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': 'less than 7.0%', 'source_type': 'LAB_VALUE', 'target': '68', 'target_type': 'LAB_VALUE', 'relationship': 'CAUSES', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '68', 'source_type': 'LAB_VALUE', 'target': 'tirzepatide-treated', 'target_type': 'DETAILED_DESCRIPTION', 'relationship': 'INFLUENCES', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': 'tirzepatide-treated', 'source_type': 'DETAILED_DESCRIPTION', 'target': '36', 'target_type': 'LAB_VALUE', 'relationship': 'MEASURED_BY', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '36', 'source_type': 'LAB_VALUE', 'target': 'insulin lispro-treated', 'target_type': 'DETAILED_DESCRIPTION', 'relationship': 'LOCATED_IN', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': 'insulin lispro-treated', 'source_type': 'DETAILED_DESCRIPTION', 'target': 'Body Weight Changes', 'target_type': 'DIAGNOSTIC_PROCEDURE', 'relationship': 'FUNDED_BY', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': 'Body Weight Changes', 'source_type': 'DIAGNOSTIC_PROCEDURE', 'target': '90 kg', 'target_type': 'LAB_VALUE', 'relationship': 'REGULATED_BY', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '90 kg', 'source_type': 'LAB_VALUE', 'target': 'body weight', 'target_type': 'DIAGNOSTIC_PROCEDURE', 'relationship': 'ASSOCIATED_WITH', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': 'body weight', 'source_type': 'DIAGNOSTIC_PROCEDURE', 'target': '−9.0 kg', 'target_type': 'LAB_VALUE', 'relationship': 'USED_FOR', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '−9.0 kg', 'source_type': 'LAB_VALUE', 'target': 'tirzepatide', 'target_type': 'DETAILED_DESCRIPTION', 'relationship': 'TREATS', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': 'tirzepatide', 'source_type': 'DETAILED_DESCRIPTION', 'target': '−3.2 kg', 'target_type': 'LAB_VALUE', 'relationship': 'CAUSES', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '−3.2 kg', 'source_type': 'LAB_VALUE', 'target': 'with insulin lispro', 'target_type': 'DETAILED_DESCRIPTION', 'relationship': 'INFLUENCES', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': 'with insulin lispro', 'source_type': 'DETAILED_DESCRIPTION', 'target': 'week 52', 'target_type': 'DATE', 'relationship': 'MEASURED_BY', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': 'week 52', 'source_type': 'DATE', 'target': '−6.7 kg', 'target_type': 'LAB_VALUE', 'relationship': 'LOCATED_IN', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '−6.7 kg', 'source_type': 'LAB_VALUE', 'target': 'with 5 mg tirzepatide', 'target_type': 'DETAILED_DESCRIPTION', 'relationship': 'FUNDED_BY', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': 'with 5 mg tirzepatide', 'source_type': 'DETAILED_DESCRIPTION', 'target': '−9.2 kg', 'target_type': 'LAB_VALUE', 'relationship': 'REGULATED_BY', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '−9.2 kg', 'source_type': 'LAB_VALUE', 'target': '−11.0 kg', 'target_type': 'LAB_VALUE', 'relationship': 'ASSOCIATED_WITH', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '−11.0 kg', 'source_type': 'LAB_VALUE', 'target': '15 mg tirzepatide', 'target_type': 'DETAILED_DESCRIPTION', 'relationship': 'USED_FOR', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '15 mg tirzepatide', 'source_type': 'DETAILED_DESCRIPTION', 'target': 'All tirzepatide doses were superior to insulin lispro', 'target_type': 'DETAILED_DESCRIPTION', 'relationship': 'TREATS', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': 'All tirzepatide doses were superior to insulin lispro', 'source_type': 'DETAILED_DESCRIPTION', 'target': 'reductions', 'target_type': 'LAB_VALUE', 'relationship': 'CAUSES', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': 'reductions', 'source_type': 'LAB_VALUE', 'target': 'fasting serum glucose', 'target_type': 'DIAGNOSTIC_PROCEDURE', 'relationship': 'INFLUENCES', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': 'fasting serum glucose', 'source_type': 'DIAGNOSTIC_PROCEDURE', 'target': 'all', 'target_type': 'DETAILED_DESCRIPTION', 'relationship': 'MEASURED_BY', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': 'all', 'source_type': 'DETAILED_DESCRIPTION', 'target': 'insulin lispro', 'target_type': 'DETAILED_DESCRIPTION', 'relationship': 'LOCATED_IN', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': 'insulin lispro', 'source_type': 'DETAILED_DESCRIPTION', 'target': 'mean daily', 'target_type': 'DETAILED_DESCRIPTION', 'relationship': 'FUNDED_BY', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': 'mean daily', 'source_type': 'DETAILED_DESCRIPTION', 'target': '2-hour postprandial', 'target_type': 'DETAILED_DESCRIPTION', 'relationship': 'REGULATED_BY', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '2-hour postprandial', 'source_type': 'DETAILED_DESCRIPTION', 'target': 'glucose', 'target_type': 'DIAGNOSTIC_PROCEDURE', 'relationship': 'ASSOCIATED_WITH', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': 'glucose', 'source_type': 'DIAGNOSTIC_PROCEDURE', 'target': '7-point self-monitored blood glucose profile', 'target_type': 'DETAILED_DESCRIPTION', 'relationship': 'USED_FOR', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '7-point self-monitored blood glucose profile', 'source_type': 'DETAILED_DESCRIPTION', 'target': '65 to 78 mg/dL', 'target_type': 'LAB_VALUE', 'relationship': 'TREATS', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '65 to 78 mg/dL', 'source_type': 'LAB_VALUE', 'target': '65 mg/dL', 'target_type': 'LAB_VALUE', 'relationship': 'CAUSES', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '65 mg/dL', 'source_type': 'LAB_VALUE', 'target': '≤6.5%', 'target_type': 'LAB_VALUE', 'relationship': 'INFLUENCES', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '≤6.5%', 'source_type': 'LAB_VALUE', 'target': 'zepatide-treated', 'target_type': 'DETAILED_DESCRIPTION', 'relationship': 'MEASURED_BY', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': 'zepatide-treated', 'source_type': 'DETAILED_DESCRIPTION', 'target': '<5.7%', 'target_type': 'LAB_VALUE', 'relationship': 'LOCATED_IN', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '<5.7%', 'source_type': 'LAB_VALUE', 'target': '<7.', 'target_type': 'LAB_VALUE', 'relationship': 'FUNDED_BY', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '<7.', 'source_type': 'LAB_VALUE', 'target': 'Basal Insulin', 'target_type': 'PERSON', 'relationship': 'REGULATED_BY', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': 'Basal Insulin', 'source_type': 'PERSON', 'target': '2', 'target_type': 'CARDINAL', 'relationship': 'ASSOCIATED_WITH', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '2', 'source_type': 'CARDINAL', 'target': 'November 7, 2023', 'target_type': 'DATE', 'relationship': 'USED_FOR', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': 'November 7, 2023', 'source_type': 'DATE', 'target': '330', 'target_type': 'CARDINAL', 'relationship': 'TREATS', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '330', 'source_type': 'CARDINAL', 'target': 'Number 17', 'target_type': 'DATE', 'relationship': 'CAUSES', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': 'Number 17', 'source_type': 'DATE', 'target': '1633', 'target_type': 'DATE', 'relationship': 'INFLUENCES', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '1633', 'source_type': 'DATE', 'target': '2023', 'target_type': 'DATE', 'relationship': 'MEASURED_BY', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '2023', 'source_type': 'DATE', 'target': 'American Medical Association', 'target_type': 'ORG', 'relationship': 'LOCATED_IN', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': 'American Medical Association', 'source_type': 'ORG', 'target': 'F. Hoffmann - La Roche LTD', 'target_type': 'PERSON', 'relationship': 'FUNDED_BY', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': 'F. Hoffmann - La Roche LTD', 'source_type': 'PERSON', 'target': '10/02/2024', 'target_type': 'DATE', 'relationship': 'REGULATED_BY', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '10/02/2024', 'source_type': 'DATE', 'target': 'between October 19, 2020', 'target_type': 'DATE', 'relationship': 'ASSOCIATED_WITH', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': 'between October 19, 2020', 'source_type': 'DATE', 'target': 'November 1, 2022', 'target_type': 'DATE', 'relationship': 'USED_FOR', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': 'November 1, 2022', 'source_type': 'DATE', 'target': '2267', 'target_type': 'CARDINAL', 'relationship': 'TREATS', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '2267', 'source_type': 'CARDINAL', 'target': '1428', 'target_type': 'DATE', 'relationship': 'CAUSES', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '1428', 'source_type': 'DATE', 'target': '1425', 'target_type': 'DATE', 'relationship': 'INFLUENCES', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '1425', 'source_type': 'DATE', 'target': 'at least one', 'target_type': 'CARDINAL', 'relationship': 'MEASURED_BY', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': 'at least one', 'source_type': 'CARDINAL', 'target': '824', 'target_type': 'CARDINAL', 'relationship': 'LOCATED_IN', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '824', 'source_type': 'CARDINAL', 'target': '58%', 'target_type': 'PERCENT', 'relationship': 'FUNDED_BY', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '58%', 'source_type': 'PERCENT', 'target': '14 years', 'target_type': 'DATE', 'relationship': 'REGULATED_BY', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '14 years', 'source_type': 'DATE', 'target': '90.5 kg', 'target_type': 'QUANTITY', 'relationship': 'ASSOCIATED_WITH', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '90.5 kg', 'source_type': 'QUANTITY', 'target': '157', 'target_type': 'CARDINAL', 'relationship': 'USED_FOR', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '157', 'source_type': 'CARDINAL', 'target': '46 IU/day', 'target_type': 'DATE', 'relationship': 'TREATS', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '46 IU/day', 'source_type': 'DATE', 'target': '0.53 IU/kg/day', 'target_type': 'MONEY', 'relationship': 'CAUSES', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '0.53 IU/kg/day', 'source_type': 'MONEY', 'target': 'US', 'target_type': 'GPE', 'relationship': 'INFLUENCES', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': 'US', 'source_type': 'GPE', 'target': '13%', 'target_type': 'PERCENT', 'relationship': 'MEASURED_BY', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '13%', 'source_type': 'PERCENT', 'target': '53%', 'target_type': 'PERCENT', 'relationship': 'LOCATED_IN', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '53%', 'source_type': 'PERCENT', 'target': 'Hispanic', 'target_type': 'NORP', 'relationship': 'FUNDED_BY', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': 'Hispanic', 'source_type': 'NORP', 'target': '89%', 'target_type': 'PERCENT', 'relationship': 'REGULATED_BY', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '89%', 'source_type': 'PERCENT', 'target': '87%–92%', 'target_type': 'PERCENT', 'relationship': 'ASSOCIATED_WITH', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '87%–92%', 'source_type': 'PERCENT', 'target': '87%', 'target_type': 'PERCENT', 'relationship': 'USED_FOR', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '87%', 'source_type': 'PERCENT', 'target': '6', 'target_type': 'CARDINAL', 'relationship': 'TREATS', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '6', 'source_type': 'CARDINAL', 'target': '73', 'target_type': 'CARDINAL', 'relationship': 'CAUSES', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '73', 'source_type': 'CARDINAL', 'target': '7.7%', 'target_type': 'PERCENT', 'relationship': 'INFLUENCES', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '7.7%', 'source_type': 'PERCENT', 'target': '2A', 'target_type': 'CARDINAL', 'relationship': 'MEASURED_BY', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '2A', 'source_type': 'CARDINAL', 'target': '95%', 'target_type': 'PERCENT', 'relationship': 'LOCATED_IN', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '95%', 'source_type': 'PERCENT', 'target': '5', 'target_type': 'CARDINAL', 'relationship': 'FUNDED_BY', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '5', 'source_type': 'CARDINAL', 'target': '10', 'target_type': 'CARDINAL', 'relationship': 'REGULATED_BY', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '10', 'source_type': 'CARDINAL', 'target': '15', 'target_type': 'CARDINAL', 'relationship': 'ASSOCIATED_WITH', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '15', 'source_type': 'CARDINAL', 'target': 'eFigure 4A', 'target_type': 'ORG', 'relationship': 'USED_FOR', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': 'eFigure 4A', 'source_type': 'ORG', 'target': '68%', 'target_type': 'PERCENT', 'relationship': 'TREATS', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '68%', 'source_type': 'PERCENT', 'target': '483', 'target_type': 'CARDINAL', 'relationship': 'CAUSES', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '483', 'source_type': 'CARDINAL', 'target': '716', 'target_type': 'CARDINAL', 'relationship': 'INFLUENCES', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '716', 'source_type': 'CARDINAL', 'target': '36%', 'target_type': 'PERCENT', 'relationship': 'MEASURED_BY', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '36%', 'source_type': 'PERCENT', 'target': '256', 'target_type': 'CARDINAL', 'relationship': 'LOCATED_IN', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '256', 'source_type': 'CARDINAL', 'target': 'kg', 'target_type': 'PERSON', 'relationship': 'FUNDED_BY', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': 'kg', 'source_type': 'PERSON', 'target': '2B', 'target_type': 'CARDINAL', 'relationship': 'REGULATED_BY', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '2B', 'source_type': 'CARDINAL', 'target': 'Exploratory Endpoints\\nGreater', 'target_type': 'PERSON', 'relationship': 'ASSOCIATED_WITH', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': 'Exploratory Endpoints\\nGreater', 'source_type': 'PERSON', 'target': 'daily', 'target_type': 'DATE', 'relationship': 'USED_FOR', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': 'daily', 'source_type': 'DATE', 'target': '2-hour', 'target_type': 'TIME', 'relationship': 'TREATS', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '2-hour', 'source_type': 'TIME', 'target': '7', 'target_type': 'CARDINAL', 'relationship': 'CAUSES', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '7', 'source_type': 'CARDINAL', 'target': '22%', 'target_type': 'PERCENT', 'relationship': 'INFLUENCES', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '22%', 'source_type': 'PERCENT', 'target': '5.7%', 'target_type': 'PERCENT', 'relationship': 'MEASURED_BY', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '5.7%', 'source_type': 'PERCENT', 'target': '18%', 'target_type': 'PERCENT', 'relationship': 'LOCATED_IN', 'evidence': 'Fallback relationship based on entity proximity'}, {'source': '18%', 'source_type': 'PERCENT', 'target': '3%', 'target_type': 'PERCENT', 'relationship': 'FUNDED_BY', 'evidence': 'Fallback relationship based on entity proximity'}]\n",
      "Graph created with 153 nodes and 152 relationships.\n"
     ]
    }
   ],
   "source": [
    "import os\n",
    "import json\n",
    "from typing import List, Tuple, Dict\n",
    "from transformers import pipeline\n",
    "from openai import OpenAI\n",
    "import spacy\n",
    "import networkx as nx\n",
    "import matplotlib.pyplot as plt\n",
    "from neo4j import GraphDatabase\n",
    "from dotenv import load_dotenv\n",
    "\n",
    "load_dotenv()\n",
    "\n",
    "# Load environment variables\n",
    "API_KEY = os.getenv(\"OPENAI_API_KEY\")\n",
    "\n",
    "# Initialize NER model\n",
    "def load_ner_model(model_name: str):\n",
    "    return pipeline(\n",
    "        \"token-classification\",\n",
    "        model=model_name,\n",
    "        aggregation_strategy=\"simple\"\n",
    "    )\n",
    "\n",
    "# Load spaCy model\n",
    "def load_spacy_model():\n",
    "    try:\n",
    "        return spacy.load(\"en_core_web_sm\")\n",
    "    except OSError:\n",
    "        print(\"Downloading spaCy language model...\")\n",
    "        spacy.cli.download(\"en_core_web_sm\")\n",
    "        return spacy.load(\"en_core_web_sm\")\n",
    "\n",
    "# Extract entities using both models\n",
    "def extract_entities(text: str, ner_model, nlp) -> List[Tuple[str, str]]:\n",
    "    ner_results = ner_model(text)\n",
    "    entities = [(res[\"word\"], res[\"entity_group\"]) for res in ner_results]\n",
    "    \n",
    "    doc = nlp(text)\n",
    "    spacy_entities = [(ent.text, ent.label_) for ent in doc.ents]\n",
    "    \n",
    "    all_entities = entities + spacy_entities\n",
    "    unique_entities = []\n",
    "    seen = set()\n",
    "    for entity, entity_type in all_entities:\n",
    "        if entity.lower() not in seen:\n",
    "            unique_entities.append((entity, entity_type))\n",
    "            seen.add(entity.lower())\n",
    "    return unique_entities\n",
    "\n",
    "# Generate relationships using OpenAI\n",
    "def generate_relations(text: str, entities: List[Tuple[str, str]], openai_client, openai_model: str) -> List[Dict]:\n",
    "    entities_str = \"\\n\".join([\n",
    "        f\"{idx+1}. {entity} (Type: {entity_type})\"\n",
    "        for idx, (entity, entity_type) in enumerate(entities)\n",
    "    ])\n",
    "    \n",
    "    prompt = f\"\"\"\n",
    "        You are a medical relationship extraction assistant. Your task is to identify meaningful relationships between entities mentioned in clinical trial text and output them in a structured JSON format.\n",
    "\n",
    "        ### Text Context:\n",
    "        {text}\n",
    "\n",
    "        ### Extracted Entities:\n",
    "        The following are entities extracted from the text, along with their respective types:\n",
    "        {entities_str}\n",
    "\n",
    "        ### Guidelines:\n",
    "        1. Identify relationships such as:\n",
    "        - TREATS: When an intervention (e.g., drug or procedure) is used to treat a condition.\n",
    "        - ASSOCIATED_WITH: When an entity is linked or co-occurs with another (e.g., symptoms associated with a disease).\n",
    "        - CAUSES: When one entity (e.g., risk factor) leads to another (e.g., disease).\n",
    "        - MEASURED_BY: When a measurement (e.g., biomarker or lab test) evaluates an entity.\n",
    "        - LOCATED_IN: When a geographic location is associated with an entity.\n",
    "        - FUNDED_BY: When an organization funds a study or trial.\n",
    "        - REGULATED_BY: When an entity is overseen by a regulatory body.\n",
    "\n",
    "        2. Use the provided entities to determine relationships based on the text context. Always provide evidence from the text supporting the relationship.\n",
    "\n",
    "        3. For each relationship, include:\n",
    "        - **source**: The name of the first entity.\n",
    "        - **source_type**: The type of the first entity (e.g., Drug, Disease, Organization).\n",
    "        - **target**: The name of the second entity.\n",
    "        - **target_type**: The type of the second entity.\n",
    "        - **relationship**: The type of relationship between the two entities.\n",
    "        - **evidence**: Supporting evidence extracted directly from the text.\n",
    "\n",
    "        ### Expected Output Format:\n",
    "        Return the output in JSON format as shown below:\n",
    "        [\n",
    "            {{\n",
    "                \"source\": \"Entity1 Name\",\n",
    "                \"source_type\": \"Entity1 Type\",\n",
    "                \"target\": \"Entity2 Name\",\n",
    "                \"target_type\": \"Entity2 Type\",\n",
    "                \"relationship\": \"RELATIONSHIP_TYPE\",\n",
    "                \"evidence\": \"Supporting text evidence\"\n",
    "            }},\n",
    "            ...\n",
    "        ]\n",
    "\n",
    "        ### Example:\n",
    "        Input Entities:\n",
    "        1. \"Aspirin\" (Type: Drug)\n",
    "        2. \"Heart Attack\" (Type: Disease)\n",
    "        3. \"Reduction in mortality\" (Type: Evidence)\n",
    "\n",
    "        Output Relationships:\n",
    "        [\n",
    "            {{\n",
    "                \"source\": \"Aspirin\",\n",
    "                \"source_type\": \"Drug\",\n",
    "                \"target\": \"Heart Attack\",\n",
    "                \"target_type\": \"Disease\",\n",
    "                \"relationship\": \"TREATS\",\n",
    "                \"evidence\": \"Aspirin has been shown to reduce the risk of heart attacks.\"\n",
    "            }}\n",
    "        ]\n",
    "\n",
    "        Based on the provided text, extract and structure the relationships as described.\n",
    "        \"\"\"\n",
    "\n",
    "    \n",
    "    try:\n",
    "        response = openai_client.chat.completions.create(\n",
    "            model=openai_model,\n",
    "            messages=[\n",
    "                {\"role\": \"system\", \"content\": \"You are an expert medical relationship extractor. Make relation based on entities and text\"},\n",
    "                {\"role\": \"user\", \"content\": prompt}\n",
    "            ],\n",
    "            max_tokens=1000,\n",
    "            temperature=0.8\n",
    "        )\n",
    "      \n",
    "\n",
    "        raw_content = response.choices[0].message.content.strip()\n",
    "        print(\"Raw OpenAI Response:\", raw_content)  # Debugging\n",
    "        \n",
    "        # Parse response as JSON\n",
    "        relations = json.loads(raw_content)\n",
    "        if not isinstance(relations, list):\n",
    "            raise ValueError(\"OpenAI response is not a valid list of relationships.\")\n",
    "        return relations\n",
    "       \n",
    "    except Exception as e:\n",
    "        print(f\"Error in relation extraction: {e}\")\n",
    "        return generate_fallback_relations(entities)\n",
    "\n",
    "# Fallback relationships\n",
    "def generate_fallback_relations(entities: List[Tuple[str, str]]) -> List[Dict]:\n",
    "    fallback_relations = []\n",
    "    relationship_types = [\"ASSOCIATED_WITH\", \"USED_FOR\", \"TREATS\", \"CAUSES\", \"INFLUENCES\",\"MEASURED_BY\",\"LOCATED_IN\",\"FUNDED_BY\",\"REGULATED_BY\"]\n",
    "    for i in range(len(entities) - 1):\n",
    "        source, source_type = entities[i]\n",
    "        target, target_type = entities[i + 1]\n",
    "        fallback_relations.append({\n",
    "            \"source\": source,\n",
    "            \"source_type\": source_type,\n",
    "            \"target\": target,\n",
    "            \"target_type\": target_type,\n",
    "            \"relationship\": relationship_types[i % len(relationship_types)],\n",
    "            \"evidence\": \"Fallback relationship based on entity proximity\"\n",
    "        })\n",
    "    return fallback_relations\n",
    "\n",
    "# Create Neo4j graph\n",
    "def create_neo4j_graph(uri: str, username: str, password: str, entities: List[Tuple[str, str]], relations: List[Dict]):\n",
    "    driver = GraphDatabase.driver(uri, auth=(username, password))\n",
    "    with driver.session() as session:\n",
    "        try:\n",
    "            session.execute_write(create_nodes, entities)\n",
    "            session.execute_write(create_relationships, relations)\n",
    "            print(f\"Graph created with {len(entities)} nodes and {len(relations)} relationships.\")\n",
    "        finally:\n",
    "            driver.close()\n",
    "\n",
    "def create_nodes(tx, entities):\n",
    "    for entity, entity_type in entities:\n",
    "        tx.run(\n",
    "            \"MERGE (n:Entity {name: $name, type: $type})\",\n",
    "            {\"name\": entity, \"type\": entity_type}\n",
    "        )\n",
    "\n",
    "def create_relationships(tx, relations):\n",
    "    \"\"\"\n",
    "    Create relationships in Neo4j.\n",
    "    \"\"\"\n",
    "    for relation in relations:\n",
    "        # Dynamically build the Cypher query with valid syntax\n",
    "        query = \"\"\"\n",
    "        MATCH (source:Entity {name: $source})\n",
    "        MATCH (target:Entity {name: $target})\n",
    "        MERGE (source)-[r:RELATES_TO]->(target)\n",
    "        SET r.relationship = $relationship, r.evidence = $evidence\n",
    "        \"\"\"\n",
    "        tx.run(query, {\n",
    "            \"source\": relation['source'],\n",
    "            \"target\": relation['target'],\n",
    "            \"relationship\": relation.get('relationship', 'RELATES_TO'),\n",
    "            \"evidence\": relation.get('evidence', 'No specific evidence')\n",
    "        })\n",
    "\n",
    "\n",
    "\n",
    "\n",
    "# Main processing function\n",
    "def process_text(text: str, ner_model, nlp, openai_client, openai_model, neo4j_config):\n",
    "    entities = extract_entities(text, ner_model, nlp)\n",
    "    relations = generate_relations(text, entities, openai_client, openai_model)\n",
    "    print('entities: ',entities)\n",
    "    print('relations: ',relations)\n",
    "    create_neo4j_graph(\n",
    "        uri=neo4j_config[\"uri\"],\n",
    "        username=neo4j_config[\"username\"],\n",
    "        password=neo4j_config[\"password\"],\n",
    "        entities=entities,\n",
    "        relations=relations\n",
    "    )\n",
    "   \n",
    "    return entities, relations\n",
    "\n",
    "\n",
    "\n",
    "if __name__ == \"__main__\":\n",
    "    text_file_path = 'data/sample.txt'\n",
    "    neo4j_url=\"bolt://localhost:7687\"\n",
    "    neo4j_username=\"neo4j\"\n",
    "    neo4j_password=\"123456789\"\n",
    "    ner_model=\"Clinical-AI-Apollo/Medical-NER\"\n",
    "    OPEN_AI_MODEL='gpt-3.5-turbo'\n",
    "\n",
    "\n",
    "    with open(text_file_path, 'r', encoding='utf-8') as f:\n",
    "        text = f.read()\n",
    "\n",
    "    ner_model = load_ner_model(ner_model)\n",
    "    nlp = load_spacy_model()\n",
    "    openai_client = OpenAI(api_key=API_KEY)\n",
    "    neo4j_config = {\n",
    "        \"uri\": neo4j_url,\n",
    "        \"username\": neo4j_username,\n",
    "        \"password\": neo4j_password\n",
    "    }\n",
    "    \n",
    "    process_text(text, ner_model, nlp, openai_client, OPEN_AI_MODEL, neo4j_config)\n"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "NER",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.10"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
